{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:09:59Z","timestamp":1790028599164,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Despite antiviral therapy (ART), 800,000 deaths still occur yearly and globally due to HIV infection. In parallel with the good virological control and the aging of this population, multiple comorbidities [HIV-associated-non-AIDS (HANA) conditions] may now be observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>HIV adult patients hospitalized in intensive care unit (ICU) from all the French region from university and non-university hospital who participate to the OutcomeRea\u2122 database on a voluntary basis over a 24-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 24,298 stays registered, 630 (2.6%) were a first ICU stay for HIV patients. Over time, the mean age and number of comorbidities (diabetes, renal and respiratory history, solid neoplasia) of patients increased. The proportion of HIV diagnosed on ICU admission decreased significantly, while the median duration of HIV disease as well as the percentage of ART-treated patients increased. The distribution of main reasons for admission remained stable over time (acute respiratory distress\u2009&gt;\u2009shock\u2009&gt;\u2009coma). We observed a significant drop in the rate of active opportunistic infection on admission, while the rate of active hemopathy (newly diagnosed or relapsed within the last 6\u00a0months prior to admission to ICU) qualifying for AIDS increased\u2014nonsignificantly\u2014with a significant increase in the anticancer chemotherapy administration in ICU. Admissions for HANA or non-HIV reasons were stable over time. In multivariate analysis, predictors of 60-day mortality were advanced age, chronic liver disease, past chemotherapy, sepsis-related organ failure assessment score\u2009&gt;\u20094 at admission, hospitalization duration before ICU admission\u2009&gt;\u200924\u00a0h, AIDS status, but not the period of admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Whereas the profile of ICU-admitted HIV patients has evolved over time (HIV better controlled but more associated comorbidities), mortality risk factors remain stable, including AIDS status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-023-04325-9","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T11:03:08Z","timestamp":1678705388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Outcomes in critically Ill HIV-infected patients between 1997 and 2020: analysis of the OUTCOMEREA multicenter cohort"],"prefix":"10.1186","volume":"27","author":[{"given":"Antoine","family":"Gaillet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"de Montmollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mait\u00e9","family":"Garrouste-Orgeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Schwebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shidasp","family":"Siami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Adrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Mourvillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Ruckly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Forel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"4325_CR1","unstructured":"World Health Organization. Global HIV and AIDS statistics, 2019. http:\/\/www.unaids.org. Accessed 1 Nov 2019"},{"key":"4325_CR2","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","volume":"382","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet. 2013;382:1525\u201333.","journal-title":"Lancet"},{"issue":"1\u20139","key":"4325_CR3","first-page":"4","volume":"173","author":"CCC Freiberg","year":"2013","unstructured":"Freiberg CCC, Kuller LH, et al. HIV Infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(1\u20139):4.","journal-title":"JAMA Intern Med"},{"key":"4325_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.201006-0836OC","volume":"183","author":"K Crothers","year":"2011","unstructured":"Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183:388\u201395.","journal-title":"Am J Respir Crit Care Med"},{"key":"4325_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/ijc.25903","volume":"129","author":"E Lanoy","year":"2011","unstructured":"Lanoy E, Spano JP, Bonnet F, et al. The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study. Int J Cancer. 2011;129:467\u201375.","journal-title":"Int J Cancer"},{"key":"4325_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/QAI.0b013e318278f3fa","volume":"62","author":"KM Akgun","year":"2013","unstructured":"Akgun KM, Gordon K, Pisani M, et al. Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected veterans. J Acquir Immune Defic Syndr. 2013;62:52\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"4325_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/00002030-199902250-00015","volume":"13","author":"S Paul","year":"1999","unstructured":"Paul S, Gilbert HM, Ziecheck W, Jacobs J, Sepkowitz KA. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection. AIDS. 1999;13(3):415\u20138. https:\/\/doi.org\/10.1097\/00002030-199902250-00015.","journal-title":"AIDS"},{"key":"4325_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/QAI.0b013e3181c8ef22","volume":"54","author":"NF Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone NF, Grandits G, Echols S, et al. Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use? J Acquir Immune Defic Syndr. 2010;54:248\u201357.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4325_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/QAI.0b013e3181bcdc16","volume":"53","author":"BR Yehia","year":"2010","unstructured":"Yehia BR, Fleishman JA, Hicks PL, Ridore M, Moore RD, Gebo KA. Inpatient health services utilization among HIV-infected adult patients in care 2002\u20132007. J Acquir Immune Defic Syndr. 2010;53:397\u2013404.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"4325_CR10","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1097\/CCM.0b013e31827caa46","volume":"41","author":"KM Akgun","year":"2013","unstructured":"Akgun KM, Tate JP, Pisani M, et al. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med. 2013;41(6):1458\u201367.","journal-title":"Crit Care Med"},{"key":"4325_CR11","first-page":"2610873","volume":"2016","author":"A Kwizera","year":"2016","unstructured":"Kwizera A, Nabukenya M, Peter A, Semogerere L, Ayebale E, Katabira C, et al. Clinical characteristics and short-term outcomes of HIV patients admitted to an african intensive care unit. Crit Care Res Pract. 2016;2016:2610873.","journal-title":"Crit Care Res Pract"},{"key":"4325_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s11904-019-00460-7","volume":"16","author":"J Botha","year":"2019","unstructured":"Botha J, Fabian J, Etheredge H, Conradie F, Tiemessen CT. HIV and solid organ transplantation: where are we now. Curr HIV AIDS Rep. 2019;16:404\u201313.","journal-title":"Curr HIV AIDS Rep"},{"key":"4325_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15257","author":"S Madan","year":"2019","unstructured":"Madan S, Patel SR, Saeed O, Sims DB, Shin JJ, Goldstein DJ, et al. Outcomes of heart transplantation in patients with human immunodefciency virus. Am J Transplant. 2019. https:\/\/doi.org\/10.1111\/ajt.15257.","journal-title":"Am J Transplant"},{"issue":"11","key":"4325_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1136\/thx.2006.072256","volume":"62","author":"SJ Dickson","year":"2007","unstructured":"Dickson SJ, Batson S, Copas AJ, Edwards SG, Singer M, Miller RF. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax. 2007;62(11):964\u20138.","journal-title":"Thorax"},{"key":"4325_CR15","doi-asserted-by":"publisher","first-page":"847835","DOI":"10.1155\/2011\/847835","volume":"2011","author":"L Turtle","year":"2011","unstructured":"Turtle L, Vyakernam R, Menon-Johansson A, et al. Intensive care usage by HIV-positive patients in the HAART era. Interdiscip Perspect Infect Dis. 2011;2011:847835.","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"4325_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s10096-011-1196-z","volume":"30","author":"SF van Lelyveld","year":"2011","unstructured":"van Lelyveld SF, Wind CM, Mudrikova T, et al. Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit. Eur J Clin Microbiol Infect Dis. 2011;30:1085\u201393.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4325_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2110-5820-2-25","volume":"2","author":"D Morquin","year":"2012","unstructured":"Morquin D, Le Moing V, Mura T, et al. Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status. Ann Intensive Care. 2012;2:25.","journal-title":"Ann Intensive Care"},{"issue":"12","key":"4325_CR18","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1007\/s00134-014-3481-7","volume":"40","author":"F Barbier","year":"2014","unstructured":"Barbier F, Roux A, Canet E, et al. Temporal trends in critical events complicating HIV infection: 1999\u20132010 multicentre cohort study in France. Intensive Care Med. 2014;40(12):1906\u201315.","journal-title":"Intensive Care Med"},{"key":"4325_CR19","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1258\/ijsa.2011.010496","volume":"22","author":"A Adlakha","year":"2011","unstructured":"Adlakha A, Pavlou M, Walker DA, et al. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy. Int J STD AIDS. 2011;22:498\u2013504.","journal-title":"Int J STD AIDS"},{"key":"4325_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"4325_CR21","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1097\/CCM.0b013e31821b827c","volume":"39","author":"JR Zahar","year":"2011","unstructured":"Zahar JR, Timsit JF, Garrouste-Orgeas M, Francais A, Vesin A, DescorpsDeclere A, Dubois Y, Souweine B, Haouache H, Goldgran-Toledano D, Allaouchiche B, Azoulay E, Adrie C. Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med. 2011;39(8):1886\u201395. https:\/\/doi.org\/10.1097\/CCM.0b013e31821b827c.","journal-title":"Crit Care Med"},{"key":"4325_CR22","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1378\/chest.100.6.1619","volume":"100","author":"WA Knaus","year":"1991","unstructured":"Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619\u201336. https:\/\/doi.org\/10.1378\/chest.100.6.1619.","journal-title":"Chest"},{"key":"4325_CR23","first-page":"1","volume":"41","author":"Centers for Disease Control and Prevention","year":"1993","unstructured":"Centers for Disease Control and Prevention. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1993;41:1\u201319.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"4325_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/geront\/10.1_part_1.20","volume":"10","author":"S Katz","year":"1970","unstructured":"Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist Spring. 1970;10(1):20\u201330. https:\/\/doi.org\/10.1093\/geront\/10.1_part_1.20. (PMID: 5420677).","journal-title":"Gerontologist Spring"},{"issue":"7","key":"4325_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine. Intensive Care Med. 1996;22(7):707\u201310. https:\/\/doi.org\/10.1007\/BF01709751.","journal-title":"Intensive Care Med"},{"key":"4325_CR26","first-page":"269","volume":"486","author":"PH Br\u00e9chat","year":"2009","unstructured":"Br\u00e9chat PH, Lansac C, Hasni S, et al. \u00c9tude de l\u2019ATIH\u202f: prise en charge de la pr\u00e9carit\u00e9 dans les \u00e9tablissements de sant\u00e9. Gest Hosp. 2009;486:269\u201374.","journal-title":"Gest Hosp"},{"issue":"9569","key":"4325_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0140-6736(07)60597-2","volume":"369","author":"B Grinsztejn","year":"2007","unstructured":"Grinsztejn B, Nguyen B, Katlama C, Gatell J, Lazzarin A, Vittecoq D, et al. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial. Lancet. 2007;369(9569):1261\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(07)60597-2.","journal-title":"Lancet"},{"key":"4325_CR28","unstructured":"http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/250576\/WHO-HIV-2016.05-fre.pdf;jsessionid=6F1692E720C7ACA966C5C306F4D5D308?sequence=1"},{"issue":"9","key":"4325_CR29","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"J Lundgren","year":"2015","unstructured":"Lundgren J, Babiker A, Gordin F, Emery S, Grund B, Sharma S, et al. INSIGHT START study group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807. https:\/\/doi.org\/10.1056\/NEJMoa1506816.","journal-title":"N Engl J Med"},{"issue":"3","key":"4325_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515\u201326. https:\/\/doi.org\/10.1093\/biomet\/81.3.515.","journal-title":"Biometrika"},{"issue":"2","key":"4325_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00134-020-05945-3","volume":"46","author":"F Barbier","year":"2020","unstructured":"Barbier F, Mer M, Szychowiak P, Miller R, Mariotte E, Galicier L, et al. Management of HIV-infected patients in the intensive care unit. Intensive Care Med. 2020;46(2):329\u201342. https:\/\/doi.org\/10.1007\/s00134-020-05945-3.","journal-title":"Intensive Care Med"},{"issue":"3","key":"4325_CR32","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/cc9056","volume":"14","author":"I Coquet","year":"2010","unstructured":"Coquet I, Pavie J, Palmer P, Barbier F, Legriel S, Mayaux J, et al. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care. 2010;14(3):R107. https:\/\/doi.org\/10.1186\/cc9056.","journal-title":"Crit Care"},{"key":"4325_CR33","doi-asserted-by":"publisher","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","volume":"4","author":"A Zolopa","year":"2009","unstructured":"Zolopa A, Andersen J, Powderly W, et al. Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE. 2009;4:e5575.","journal-title":"PLoS ONE"},{"issue":"10","key":"4325_CR34","doi-asserted-by":"publisher","first-page":"e0186968","DOI":"10.1371\/journal.pone.0186968","volume":"12","author":"HB Andrade","year":"2017","unstructured":"Andrade HB, Shinotsuka CR, da Silva IRF, Donini CS, Yeh Li H, de Carvalho FB, et al. Highly active antiretroviral therapy for critically ill HIV patients: a systematic review and meta-analysis. PLoS ONE. 2017;12(10):e0186968.","journal-title":"PLoS ONE"},{"key":"4325_CR35","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1016\/S2352-3018(18)30110-3","volume":"5","author":"R Harding","year":"2018","unstructured":"Harding R. Palliative care as an essential component of the HIV care continuum. Lancet HIV. 2018;5:e524\u201330.","journal-title":"Lancet HIV"},{"key":"4325_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1164\/rccm.2111025","volume":"166","author":"A Morris","year":"2002","unstructured":"Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med. 2002;166:262\u20137.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04325-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04325-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04325-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T11:08:42Z","timestamp":1678705722000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04325-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4325"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04325-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1909122\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"29 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The OutcomeRea\u2122 database was declared to the \u201cComit\u00e9 consultatif fran\u00e7ais de l'informatique pour la recherche en sant\u00e9\u201d (CCTIRS) et la \u201cCommission fran\u00e7aise de l'informatique et des libert\u00e9s\u201d (CNIL, #8999262), in accordance with French law, and this study was approved by the ethical committee of the French Society of Intensive Care (SRLF). Waiver for informed consent was granted because the study does not modify patients\u2019 management and the data are anonymously collected.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"EA: Related to paper: none; Apart from the paper: fees for lectures from Gilead, Pfizer, Baxter and Alexion. His research group has been supported by Ablynx, Fisher & Payckle, Jazz Pharma, and MSD. CS: Related to paper: none; Apart from the paper: fees for speaking (Sanofi)\u2014financial support for CME (Pfizer, MSD). JFT: Related to paper: none; Apart from the paper: advisory boards: Pfizer, Gilead, Merck, BD France, Shionogi. His research group has been supported by Merck, Thermofischer, Pfizer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}